최소침습 생검 기술 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 제공 제품별, 기술별, 순환 바이오마커별, 용도별, 최종사용자별, 지역별, 경쟁별(2020-2030년)

The Global Minimally Invasive Biopsy Techniques Market, valued at USD 13.75 Billion in 2024, is projected to experience a CAGR of 10.30% to reach USD 24.76 Billion by 2030. Minimally invasive biopsy techniques involve diagnostic procedures designed to obtain tissue or fluid samples with reduced physical trauma, shorter recovery times, and decreased complication risks compared to conventional surgical biopsies. Key drivers propelling this market's growth include the rising global prevalence of cancer and other conditions necessitating definitive tissue diagnosis, an increasing patient inclination towards less invasive medical interventions, and continuous technological advancements in imaging guidance and device precision. These innovations enhance the accuracy and efficiency of sample collection, supporting broader clinical

Key Market Drivers

The increasing global burden of cancer and chronic diseases stands as a primary catalyst for the expansion of the minimally invasive biopsy techniques market. As diagnostic needs escalate for a growing patient population, the imperative for accurate and timely tissue sampling intensifies. These techniques offer a less intrusive yet highly effective method for obtaining critical diagnostic information, directly responding to the rising disease prevalence. According to the World Health Organization (WHO), on February 1, 2024, in "Global cancer burden growing, amidst mounting need for services," there were an estimated 20 million new cancer cases globally in 2022, underscoring the vast and continuous demand for robust diagnostic interventions. This widespread incidence drives healthcare systems to prioritize efficient and patient-friendly diagnostic pathways.

Key Market Challenges

The inherent technical complexity and demanding learning curve associated with specialized minimally invasive biopsy procedures represent a significant challenge to the growth of the Global Minimally Invasive Biopsy Techniques Market. These procedures require extensive training and substantial expertise from healthcare professionals to ensure optimal diagnostic yield and patient safety. This stringent requirement limits the number of practitioners qualified to perform these advanced techniques, directly impeding broader clinical adoption.

Key Market Trends

Liquid biopsy dominance and expansion represents a pivotal trend reshaping cancer diagnostics by offering minimally invasive methods for disease detection and surveillance. These blood-based tests analyze circulating tumor DNA and other biomarkers, providing a less intrusive alternative to conventional tissue biopsies, especially beneficial for inaccessible tumors or for continuous monitoring of treatment efficacy. The Association for Molecular Pathology and the College of American Pathologists collectively published 13 best practice recommendations for validating and reporting clinical circulating tumor DNA assays, indicating a growing formalization and clinical acceptance of these techniques in October 2023. This advancement facilitates earlier detection of recurrence and precise assessment of therapeutic response.

Key Market Players

• F. Hoffmann-La Roche AG
• Thermo Fisher Scientific, Inc.
• PerkinElmer Inc.
• QIAGEN NV
• Guardant Health, Inc.
• Veracyte, Inc.
• Myriad Genetics, Inc.
• Biocept, Inc.
• NeoGenomics Laboratories, Inc.
• Adaptive Biotechnologies Corporation

Report Scope:

In this report, the Global Minimally Invasive Biopsy Techniques Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Minimally Invasive Biopsy Techniques Market, By Product Offered:

• Tests
• Kits & Consumables
• Instruments

Minimally Invasive Biopsy Techniques Market, By Technique:

• Liquid Biopsy
• Optical Biopsy
• Brush Biopsy
• Pigmented Lesion Assays
• Others

Minimally Invasive Biopsy Techniques Market, By Circulating Biomarker:

• Circulating Tumor Cells (CTCs)
• Cell Free DNA (cfDNA)
• Circulating Tumor DNA (ctDNA)
• Extracellular Vesicles
• Others

Minimally Invasive Biopsy Techniques Market, By Application:

• Clinical
• Therapeutic

Minimally Invasive Biopsy Techniques Market, By End User:

• Hospitals & Clinics
• Ambulatory Care Center
• Academic & Research Institutions

Minimally Invasive Biopsy Techniques Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Minimally Invasive Biopsy Techniques Market.

Available Customizations:

Global Minimally Invasive Biopsy Techniques Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Minimally Invasive Biopsy Techniques Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product Offered (Tests, Kits & Consumables, Instruments)
  • 5.2.2. By Technique (Liquid Biopsy, Optical Biopsy, Brush Biopsy, Pigmented Lesion Assays, Others)
  • 5.2.3. By Circulating Biomarker (Circulating Tumor Cells (CTCs), Cell Free DNA (cfDNA), Circulating Tumor DNA (ctDNA), Extracellular Vesicles, Others)
  • 5.2.4. By Application (Clinical, Therapeutic)
  • 5.2.5. By End User (Hospitals & Clinics, Ambulatory Care Center, Academic & Research Institutions)
  • 5.2.6. By Region
  • 5.2.7. By Company (2024)
• 5.3. Market Map

6. North America Minimally Invasive Biopsy Techniques Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product Offered
  • 6.2.2. By Technique
  • 6.2.3. By Circulating Biomarker
  • 6.2.4. By Application
  • 6.2.5. By End User
  • 6.2.6. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Minimally Invasive Biopsy Techniques Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product Offered
      • 6.3.1.2.2. By Technique
      • 6.3.1.2.3. By Circulating Biomarker
      • 6.3.1.2.4. By Application
      • 6.3.1.2.5. By End User
  • 6.3.2. Canada Minimally Invasive Biopsy Techniques Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product Offered
      • 6.3.2.2.2. By Technique
      • 6.3.2.2.3. By Circulating Biomarker
      • 6.3.2.2.4. By Application
      • 6.3.2.2.5. By End User
  • 6.3.3. Mexico Minimally Invasive Biopsy Techniques Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product Offered
      • 6.3.3.2.2. By Technique
      • 6.3.3.2.3. By Circulating Biomarker
      • 6.3.3.2.4. By Application
      • 6.3.3.2.5. By End User

7. Europe Minimally Invasive Biopsy Techniques Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product Offered
  • 7.2.2. By Technique
  • 7.2.3. By Circulating Biomarker
  • 7.2.4. By Application
  • 7.2.5. By End User
  • 7.2.6. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Minimally Invasive Biopsy Techniques Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product Offered
      • 7.3.1.2.2. By Technique
      • 7.3.1.2.3. By Circulating Biomarker
      • 7.3.1.2.4. By Application
      • 7.3.1.2.5. By End User
  • 7.3.2. France Minimally Invasive Biopsy Techniques Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product Offered
      • 7.3.2.2.2. By Technique
      • 7.3.2.2.3. By Circulating Biomarker
      • 7.3.2.2.4. By Application
      • 7.3.2.2.5. By End User
  • 7.3.3. United Kingdom Minimally Invasive Biopsy Techniques Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product Offered
      • 7.3.3.2.2. By Technique
      • 7.3.3.2.3. By Circulating Biomarker
      • 7.3.3.2.4. By Application
      • 7.3.3.2.5. By End User
  • 7.3.4. Italy Minimally Invasive Biopsy Techniques Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product Offered
      • 7.3.4.2.2. By Technique
      • 7.3.4.2.3. By Circulating Biomarker
      • 7.3.4.2.4. By Application
      • 7.3.4.2.5. By End User
  • 7.3.5. Spain Minimally Invasive Biopsy Techniques Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product Offered
      • 7.3.5.2.2. By Technique
      • 7.3.5.2.3. By Circulating Biomarker
      • 7.3.5.2.4. By Application
      • 7.3.5.2.5. By End User

8. Asia Pacific Minimally Invasive Biopsy Techniques Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product Offered
  • 8.2.2. By Technique
  • 8.2.3. By Circulating Biomarker
  • 8.2.4. By Application
  • 8.2.5. By End User
  • 8.2.6. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Minimally Invasive Biopsy Techniques Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product Offered
      • 8.3.1.2.2. By Technique
      • 8.3.1.2.3. By Circulating Biomarker
      • 8.3.1.2.4. By Application
      • 8.3.1.2.5. By End User
  • 8.3.2. India Minimally Invasive Biopsy Techniques Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product Offered
      • 8.3.2.2.2. By Technique
      • 8.3.2.2.3. By Circulating Biomarker
      • 8.3.2.2.4. By Application
      • 8.3.2.2.5. By End User
  • 8.3.3. Japan Minimally Invasive Biopsy Techniques Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product Offered
      • 8.3.3.2.2. By Technique
      • 8.3.3.2.3. By Circulating Biomarker
      • 8.3.3.2.4. By Application
      • 8.3.3.2.5. By End User
  • 8.3.4. South Korea Minimally Invasive Biopsy Techniques Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product Offered
      • 8.3.4.2.2. By Technique
      • 8.3.4.2.3. By Circulating Biomarker
      • 8.3.4.2.4. By Application
      • 8.3.4.2.5. By End User
  • 8.3.5. Australia Minimally Invasive Biopsy Techniques Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product Offered
      • 8.3.5.2.2. By Technique
      • 8.3.5.2.3. By Circulating Biomarker
      • 8.3.5.2.4. By Application
      • 8.3.5.2.5. By End User

9. Middle East & Africa Minimally Invasive Biopsy Techniques Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product Offered
  • 9.2.2. By Technique
  • 9.2.3. By Circulating Biomarker
  • 9.2.4. By Application
  • 9.2.5. By End User
  • 9.2.6. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Minimally Invasive Biopsy Techniques Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product Offered
      • 9.3.1.2.2. By Technique
      • 9.3.1.2.3. By Circulating Biomarker
      • 9.3.1.2.4. By Application
      • 9.3.1.2.5. By End User
  • 9.3.2. UAE Minimally Invasive Biopsy Techniques Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product Offered
      • 9.3.2.2.2. By Technique
      • 9.3.2.2.3. By Circulating Biomarker
      • 9.3.2.2.4. By Application
      • 9.3.2.2.5. By End User
  • 9.3.3. South Africa Minimally Invasive Biopsy Techniques Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product Offered
      • 9.3.3.2.2. By Technique
      • 9.3.3.2.3. By Circulating Biomarker
      • 9.3.3.2.4. By Application
      • 9.3.3.2.5. By End User

10. South America Minimally Invasive Biopsy Techniques Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product Offered
  • 10.2.2. By Technique
  • 10.2.3. By Circulating Biomarker
  • 10.2.4. By Application
  • 10.2.5. By End User
  • 10.2.6. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Minimally Invasive Biopsy Techniques Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product Offered
      • 10.3.1.2.2. By Technique
      • 10.3.1.2.3. By Circulating Biomarker
      • 10.3.1.2.4. By Application
      • 10.3.1.2.5. By End User
  • 10.3.2. Colombia Minimally Invasive Biopsy Techniques Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product Offered
      • 10.3.2.2.2. By Technique
      • 10.3.2.2.3. By Circulating Biomarker
      • 10.3.2.2.4. By Application
      • 10.3.2.2.5. By End User
  • 10.3.3. Argentina Minimally Invasive Biopsy Techniques Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product Offered
      • 10.3.3.2.2. By Technique
      • 10.3.3.2.3. By Circulating Biomarker
      • 10.3.3.2.4. By Application
      • 10.3.3.2.5. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Minimally Invasive Biopsy Techniques Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. F. Hoffmann-La Roche AG
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Thermo Fisher Scientific, Inc.
• 15.3. PerkinElmer Inc.
• 15.4. QIAGEN NV
• 15.5. Guardant Health, Inc.
• 15.6. Veracyte, Inc.
• 15.7. Myriad Genetics, Inc.
• 15.8. Biocept, Inc.
• 15.9. NeoGenomics Laboratories, Inc.
• 15.10. Adaptive Biotechnologies Corporation

16. Strategic Recommendations

17. About Us & Disclaimer